See also this year's filing and all EDGAR filings for this company.
PDF Report 0001517681_2022_Propanc_Biopharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001517681')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001517681, Propanc Biopharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 6,596 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,255 |
| 3 | remainder_Assets | 2,250 |
| 4 | LiabilitiesCurrent | 3,080,674 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,553,075 |
| 9 | ResearchAndDevelopmentExpense | 230,956 |
| 10 | remainder_Expenses | -85,303 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -327,219 |
| 13 | remainder_ComprehensiveNetIncome | -574,216 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 13,101 |
| 1 | Liabilities | 3,080,674 |
| 2 | Expenses | 1,698,728 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -3,067,573 |
| 5 | NetIncome | -2,025,947 |
| 6 | ComprehensiveNetIncome | -2,313,055 |
| 7 | BaseVar | 2,846,969 |
| 8 | EconomicCapitalRatio | -4.91 |
Edgar->Model Mapping
Feature Distribution
Change over Time
